Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

1097 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
GSK : Director/Pdmr Shareholding - Form 6-K
PU
GSK : Governance and Remuneration report 2023
PU
GSK announces Dr Jeannie Lee to join the Board as Non-Executive Director | GSK
AQ
GSK announces Wendy Becker to join the Board as Non-Executive Director | GSK
AQ
GSK : announces Wendy Becker to join the Board as Non-Executive Director - Form 6-K
PU
GSK : announces Wendy Becker to join the Board as Non-Executive Director
PU
GSK : Director/Pdmr Shareholding - Form 6-K
PU
Hunt prioritises tackling inflation over tax cuts amid pressure from Tory MPs
AN
GSK CFO buys shares worth GBP321,500
AN
Haitong International Securities : The Third Asia Summit on Global Health Opens Today Haitong International Acts as Strategic Partner for the Second Consecutive Year Accelerating Healthcare Innovation and Investment Opportunities
PU
US subsidies make UK financial reform urgent, business warns
RE
UK pension system needs 'big reform' to ensure higher returns - Hunt
AN
GSK : Proxy Form 2023
PU
GSK : AGM Notice 2023
PU
GSK : Corporate governance report 2022
PU
RUBIUS THERAPEUTICS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers (form 8-K)
AQ
Rubius Therapeutics, Inc. Announces Board Changes
CI
Factbox-Activist investor Bluebell's offensive against European giants heats up
RE
Iain Mackay, Chief Financial Officer, to retire from GSK, Julie Brown appointed as successor
AQ
GSK plc - Iain Mackay, Chief Financial Officer, to retire from GSK, Julie Brown appointed as successor
AQ
GlaxoSmithKline : GSK Board changes - Form 6-K
PU
GlaxoSmithKline : GSK Board changes
PU
Board and Committee changes
AQ
GlaxoSmithKline : Board and Committee changes - Form 6-K
PU
London Stock Exchange : UK capital market reform set to receive boost as Chancellor welcomes new Taskforce
PU
GSK announces Dr Vishal Sikka to join the Board as Non-Executive Director
AQ
GlaxoSmithKline : Corporate Governance
PU
GSK Reportedly Seeks Out Investment from Sovereign Wealth Funds
CI
GSK announces Sir Dave Lewis appointed Non-Executive Chair Designate of independent Consumer Healthcare company
AQ
GSK announces Dr Harry (Hal) C. Dietz MD to join the Board as Non-Executive Director - Form 6-K
PU
GSK announces Dr Harry (Hal) C. Dietz MD to join the Board as Non-Executive Director
PU
GSK names Johns Hopkins scientist to board ahead of consumer unit spinoff
RE
GlaxoSmithKline : GSK on track with consumer split as buyout report boosts shares
RE
Elliott Investment Boss Again Questions GlaxoSmithKline on Value Creation
CI
GlaxoSmithKline Provides Information to the Shareholders
CI
Mesoblast : Management Team
PU
Bluebell Capital Provides Information to the Shareholders
CI
Activist investor Bluebell takes stake in GSK
RE
GlaxoSmithKline ( '') (Form 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
Mesoblast : Management Team
PU
GlaxoSmithKline : GSK delivers strong Q2 sales of £8.1 billion, +6% AER, +15% CER Total EPS 27.9p -39% AER, -28% CER; Adjusted EPS 28.1p +46% AER +71% CER (Form 6-K)
PU
GlaxoSmithKline ( '') (Form 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
GlaxoSmithKline : GSK appoints consumer head as CEO of new spin-off
RE
GlaxoSmithKline : Brian McNamara appointed CEO Designate of new independent Consumer Healthcare company (Form 6-K)
PU
GlaxoSmithKline : Brian McNamara appointed CEO Designate of new independent Consumer Healthcare company
PU
Early Equity Plc - Half-year Report
PR
Early Equity Plc - Acquisition and Issue of Equity
PR
GlaxoSmithKline Gets Support From Leading Shareholders Over Elliott Management Shake-Up Bid -The Times
DJ
GlaxoSmithKline Provides Information to the Shareholders
CI
RUBIUS THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
No results for this search
  1. Stock Market
  2. Advanced search
  3. Jonathan Symonds
  4. News